塞来昔布对骨科围手术期镇痛的疗效评估

被引:26
作者
郝永强
干耀恺
朱振安
机构
[1] 上海交通大学医学院附属第九人民医院骨科
关键词
塞来昔布; 骨科; 围手术期; 镇痛;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[目的]观察塞来昔布(西乐葆)对骨科围手术期患者术后镇痛的疗效及安全性。[方法]选择2004~2005年住院手术患者,共64例,随机分组,分别给予西乐葆或镇痛泵进行术后镇痛。西乐葆给药时间:一般于手术前8~12 h,即患者手术禁食前首次给药,手术后6 h患者可进食后再次给药,手术后3~5 d按手术大小及患者疼痛程度决定停药时间。给药剂量:西乐葆首次服用400 mg,大手术可加大剂量。观察患者疼痛VAS评分、药物不良反应及患者满意度。[结果]西乐葆的术后镇痛效果与镇痛泵相似,但发生不良反应比及患者总体满意度优于镇痛泵。[结论]西乐葆对手术后镇痛具有满意的疗效及安全性,适合于骨科围手术期术后镇痛。
引用
收藏
页码:131 / 133
页数:3
相关论文
共 10 条
[1]  
Efficacy and tolerability ofcelecoxib versus hydrocodone/acetaminophen in the treatment of painafter ambulatory orthopedic surgery in adults. Gimbel JS,Brugger A,Zhao W,et al. Clinical Therapeu-tics . 2001
[2]  
Efficacy of celecoxib versusibuprofen in the treatment of acute pain:a multicenter,double-blind,randomized controlled trial in acute ankle sprain. Ekman EF,Fiechtner JJ,Levy S,et al. AmJ Or-thop . 2002
[3]  
The effect of cycloox-ygenase-2 inhibition on acute and chronic donor-site pain after spinal-fusion surgery. Reuben SS,Ekman EF,Raghunathan K,et al. Regional Anesthesia and Pain Medicine . 2006
[4]  
Joint Commission on Acchreditation of Healthcare Organizations. Jt Comm Perspect . 1999
[5]  
American Pain Society Quality Improvement Committee. The Journal of The American Medical Association . 1995
[6]  
A systematic review of COX-2 inhibitorscompared with traditional NSAIDs,or different COX-2 inhibitors forpost-operative pain. Romsing J,Moiniche S. Acta Anaesthesiologica . 2004
[7]  
Gastrointestinal toxicitywith celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthri-tis and rheumatoid arthritis:the CLASS study:a randomized con-trolled trial:celecoxib long-term arthritis safety study. Silverstein FE,Faich G,Goldstein JL,et al. The Journal of The American Medical Association . 2000
[8]  
Observational study of up-per gastrointestinal haemorrhage in elderly patients given selective cy-clo~oxygenase-2 inhibitors or conventional non-steroidal anti-inflam-matory drugs. Muhammad M,Paula AR,David NJ,et al. British Medical Journal . 2002
[9]  
Gastrointestinal toxicitywith Celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthri-tis and rheumatoid arthritis The CLASS study:a randomized con-trolled trial. Silverstein FE,Faich G,Goldstein JL,et al. The Journal of The American Medical Association . 2000
[10]  
The burden of acute postoper-ative pain and the potential role of the COX-2-specific inhibitors. Stephens J,Laskin B,Pashos C,et al. Rheumatology . 2003